When will MindMaze Therapeutics present at the ACRM Annual Fall Conference?

MindMaze Therapeutics is scheduled to present at the American Congress of Rehabilitation Medicine (ACRM) Annual Fall Conference on October 13–15, 2026. The conference will take place in Washington, DC.

When will MindMaze Therapeutics present at HLTH USA 2026?

MindMaze Therapeutics is scheduled to present at HLTH USA 2026 on November 17, 2026 at 3:30 p.m. PST. The conference will take place in Las Vegas, NV.

What will MindMaze Therapeutics showcase at the industry conferences?

MindMaze Therapeutics said it will exhibit its neurotechnology solutions and present its growing body of real-world evidence at the industry conferences. The company said these presentations will highlight the potential of its solutions to improve the delivery of neurorehabilitation across the continuum of care.

Can investors arrange one-on-one meetings with MindMaze Therapeutics management?

Yes, MindMaze Therapeutics said management will be available for one-on-one meetings. Investors interested in meeting with the company are invited to contact ir@mindmazetherapeutics.com.

Where will MindMaze Therapeutics post presentation materials and replays?

MindMaze Therapeutics said relevant presentation materials and replays, where available, will be posted on the company’s website.

What does MindMaze Therapeutics do?

MindMaze Therapeutics develops scalable, precision neurotherapeutics by integrating advanced software, proprietary sensors and AI-driven data analytics. The company says its approach provides a continuum of care from the acute hospital phase to outpatient treatment and home-based therapy.

Which conditions are MindMaze Therapeutics' products designed to address?

MindMaze Therapeutics says its FDA-listed and CE-marked products are designed for stroke, Parkinson’s disease and other neurological disorders. The company also says the products are intended to address the shortage of specialised clinicians by offering scalable, reimbursable solutions.

Where do MindMaze Therapeutics shares trade and what is the ticker symbol?

MindMaze Therapeutics shares trade on SIX Swiss Exchange under the ticker symbol SIX: MMTX.

What does MindMaze Therapeutics say about its research and development capabilities?

MindMaze Therapeutics says it has an extensive library of clinical validation and a robust research and development pipeline. The company describes its clinical validation as rigorous.

Home
News Intelligence
MindMaze Therapeutics Holding SA
MindMaze Therapeutics Announces Upcoming Investor and Industry Conference Appearances

Back to all MindMaze Therapeutics Holding SA press releases

MindMaze Therapeutics Holding SA

OTCQB:MMTZF
SIX:MMTX

MindMaze Therapeutics Announces Upcoming Investor and Industry Conference Appearances

Published Tuesday, 01 September 2026, 05:00 AM

Get alerts

Plain English summaries when MindMaze Therapeutics Holding SA announces news.

At a glance

Company: MindMaze Therapeutics Holding SA
Listings: OTCQB:MMTZF, SIX:MMTX
Announcement type: Corporate update
Published: Tuesday, 01 September 2026, 05:00 AM
Source announcement: eqs-news.com

FAQSIR Generated from this announcement View original release below for safe harbor and regulatory notices

Announcement Summary

MindMaze Therapeutics Holding SA (SIX: MMTX) announced participation in investor and industry conferences.

American Congress of Rehabilitation Medicine (ACRM) Annual Fall Conference: Washington, DC, October 13–15, 2026.
HLTH USA 2026: Las Vegas, NV; presentation November 17, 2026, at 3:30 p.m. PST.
The company will exhibit neurotechnology solutions and present real-world evidence at both conferences.

Investors are invited to contact [email protected] for one-on-one meetings; materials and available replays will be posted on the company’s website.

Investor FAQs

MindMaze Therapeutics announced that it will participate in several upcoming investor and industry conferences in the United States and Europe. The company said management will be available for one-on-one meetings.

Source announcement

Company: MindMaze Therapeutics Holding SA
Title: MindMaze Therapeutics to Present at Upcoming Investor and Industry Conferences
Published: Tuesday, 01 September 2026, 05:00 AM
Source site: eqs-news.com

Read the source announcement on eqs-news.com

FAQSIR's summary and investor FAQs are generated by AI from the text of this announcement alone, without information from other sources.

Figures, forecasts and other claims are the announcement's, not FAQSIR's. FAQSIR does not independently verify them.

Read the original press release

Full text as published, unedited.

Loading the original release…

Important Notice And Disclaimer

This article was generated by an artificial intelligence system from an announcement published by the issuer. It has not been independently researched, verified, or edited by a journalist, and no person holds editorial responsibility for its wording.

The issuer named in this article has not paid for this page and has no commercial relationship with its publisher. This is an unpaid evaluation preview produced from announcements the issuer published publicly, and it is not independent editorial coverage.

This article does not provide any financial advice and is not a recommendation to deal in any securities or product. Investments may fall in value and an investor may lose some or all of their investment. Past performance is not an indicator of future performance.

Ask about this announcement

Answers drawn only from this announcement

Reading the announcement…